Novigenix SA

Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for early detection of disease, development of novel therapeutics, and drug target discovery. The Novigenix proprietary LITOSeekTM platform is an AI-enabled RNA analytic platform optimized for mapping the response of the immune system to onset and progression of disease. Our analytical pipelines integrate patient multi-omics data with advanced Machine Learning and artificial intelligence approaches to provide actionable insights and precision solutions. Our liquid biopsy products and services include a suite of biopharma solutions for clinical development of novel therapies, drug target discovery, and early detection of Colorectal Cancer. Novigenix...

In vitro diagnostics,liquid biopsy,oncology,screening tests,cancer diagnostics,blood tests,and early cancer detection

Novigenix sa operates in the Biotechnology industry.

Novigenix sa's revenue is 11m - 100m

Novigenix sa has 11 - 50 employees.